Artivion, Inc. (AORT) financial statements and ratios from SEC XBRL: revenue $441.33M (TTM), net margin 2.2%, revenue growth 11.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $441.33M |
| Net Margin | 2.2% |
| Revenue Growth (YoY) | 11.3% |
| EPS Growth (YoY) | -1033.3% |
| FCF Growth (YoY) | -202.5% |
| EV / EBITDA | 36.5 |
| Price / Book | 3.06 |
| Price / Sales | 2.89 |
| FCF Yield | -0.7% |
| DCF Value (model) | $4.76 |
| DCF Upside vs Price | -83.0% |
| Altman Z-Score | 2.73 (grey) |
| Piotroski F-Score | 7/9 |
| Sector P/E (Healthcare) | 21.6 |
AORT overview · AORT earnings · AORT KPIs · AORT investor relations · AORT ownership · AORT peers · AORT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.